1. <li id="239dt"></li><dd id="239dt"><noscript id="239dt"></noscript></dd>

      <rp id="239dt"></rp>
      <progress id="239dt"><big id="239dt"></big></progress>
    2. <tbody id="239dt"><noscript id="239dt"><video id="239dt"></video></noscript></tbody>

      陪同口譯

      近年來,對于上海陪同口譯(Escor…

      論文翻譯

      如何確保論文翻譯的專業性? 論…

      視頻翻譯

      為什么要翻譯視頻字幕翻譯視頻字幕使您…

      翻譯認證蓋章

      翻譯認證蓋章服務條款 尊敬的客戶感…

      網站本地化

      迪朗上海翻譯公司是一家專業的上海…

      展會口譯

      展會口譯服務簡介:上海迪朗翻譯公司是…

      同聲傳譯

      迪朗(上海)翻譯公司是嚴格按照ITC…

      «
      »

      上海復旦大學醫學報告翻譯認證蓋章(出院小結,診斷書)

      翻譯中英文對照文本
      seg
      上海中醫藥大學附屬龍華醫院出院小結
      Discharge Summary of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
      姓名:***   科別:腫瘤七科    病區:二十六病區   床號:14住院號:0823817
      Name: *** Department: Oncology the 7th Department Ward No.: 26 Bed No.: 14 Hospital No.: 0823817
      更診時間及后續治療:門診隨訪,定期復查,聯系電話64385700-8163(醫),8168 (護);我科來電顯示:02133324000
      Time in service of hospital and follow-up treatment: outpatient follow-up, and regular review, Contact Number 64385700-8163 (medical), 8168 (nursing); Tel. Number of our department: 02133324000
      相關醫生門診安排:
      Outpatient Arrangements of Related MD :
      特需門診:楊金祖 周三全天(總院)
      VIP Clinic:  Jinzu Yang all day on Wednesday (General Hospital)
      專家門診:楊金祖 周二下午(總院);楊金祖 周四上午(總院):武清 周一下午,周三上午(總院)
      Specialist clinic: Yang Jinzu Tuesday afternoon (General Hospital); Yang Jinzu Thursday morning (General Hospital): Wuqing Monday afternoon, Wednesday morning (General Hospital)
      普通門診:周三下午
      General clinic: Wednesday afternoon
      病房抄方時間:周三下午
      Time for copying prescriptions in the ward: Wednesday afternoon
      轉外院治療:
      Transfer to another hospital for treatment:
      后續醫療服務機構名稱及地址:
      Name and address of follow-up medical service institution:
      中醫調護:避風寒.調飲食,暢情志,慎起居
      Traditional Chinese medicine care: avoid wind and cold, adjust diet, smooth emotions, and be cautious in daily life
      緊急就醫的情況:如出現發熱、惡心嘔吐等不適癥狀,諳立即至急診就診。
      Emergency medical treatment: If symptoms such as fever, nausea, or vomiting occurs, go to the emergency department immediately.
      治療結果 好轉
      Treatment results: Improved
      主治醫師:
      Attending Physician:
      日期:2023-03-10
      Date: Mar. 10, 2023
      住院醫師:  日期:2023年03月10日
      Residency Physician: Date: Mar. 10, 2023
      爨掃描全能王創建
      上海中醫藥大學附屬龍華醫院出院小結
      Discharge Summary of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
      姓名:***   科別:腫瘤七科   病區:二十六病區   床號:14住院號:0823817
      Name: ***  Department: Oncology the 7th Department  Ward No.:26  Bed No.: 14 Hospital No.: 0823817
      umol/L ,尿素(干式)5. 01 mmol/L ,尿酸(干式)307 umol/L,鉀(干式)4. 1 mmol/L,鈉(干式) 132.9 mmol/L  .
      umol/L, urea (dry) 5.01 mmol/L, uric acid (dry) 307 umol/L, potassium (dry) 4.1 mmol/L, sodium (dry) 132.9 mmol/L.
      特殊檢查結果及主要會診(注明日期與檢查號) 無
      Special inspection results and major consultations (specify date and inspection number) : None
      病程與治療結果(注明手術日期、手術名稱、輸血以及搶救情況)
      Disease course and treatment results (indicate operation date, operation name, blood transfusion and rescue status)
      患者四月前因反復腹部隱痛不適,遂于2022.
      The patient had abdominal pain and discomfort repeatly in four months ago, and then
      9月至復旦大學附屬腫瘤醫院就診,2022.09. 15腫瘤標志物:CA199:7459U/ml, CA125:79. 2U/ml, CA153:4. 94U/ml, CA724:2. 32U/ml, CA50: >500IU/ml, CA242: > 200U/ml.
      visited Fudan University Shanghai Cancer Center on Sept. 15 2022. Tumor markers: CA199: 7459U/ml, CA125: 79. 2U/ml, CA153: 4. 94U/ml, CA724: 2. 32U/ml, CA50: > 500IU/ml, CA242: > 200U/ml.
      AFP:2.43ng/ml, CEA: 165ng/ml.
      AFP: 2.43ng/ml, CEA: 165ng/ml.
      2022-09-15 查【PET-CT】報告示:1.胰體部軟組織腫塊影,FDG 代謝增高,考慮為MT可能大,侵犯左側腎上腺及胃后壁。
      2022-09-15 [PET-CT] report showed: 1. Soft tissue mass shadows in the body of the pancreas, increased FDG metabolism, it is considered that the MT possibiity is high, invading the left adrenal gland and the back wall of the stomach.
      2022. 09. 20行超聲引導下胰體尾腫瘤穿刺,2022- 09-21穿刺細胞病理診斷示:見腺癌細胞,遂于腫瘤醫院2022-09-22至2023-01-12行AG方案化療(紫杉醇 170mg dl+吉西他濱1.4g dl) 4程.2023-01-31于復旦大學附屬腫瘤醫院[PET-CT]示:1.胰腺癌化療后,胰體MT較前相仿,仍FDG代謝異常增高,侵犯左側腎上腺及胃后壁;新見胸骨、右側股骨上段轉移;新見兩側鎖骨上淋巴結轉移可能。
      2022.09.20 Ultrasound-guided pancreatic tail tumor puncture, 2022-09-21 Puncture cytological diagnosis showed: adenocarcinoma cells were seen, and AG chemotherapy was performed in the Cancer Hospital from Sept. 22, 2022 to Jan. 12, 2023 (Paclitaxel 170mg dl + Gemcitabine 1.4g dl) 4 courses. On Jan. 31,2023 at Fudan University Cancer Hospital, the [PET-CT] showed: 1. After pancreatic cancer chemotherapy, pancreatic MT was similar as before,  FDG metabolism was still abnormally increased, Invading the left adrenal gland and the posterior gastric wall; new metastasis to the sternum and right upper femur; new possible metastasis to supraclavicular lymph nodes on both sides.
      2023-02-09、2023-03-02我科行AG方案C5治療:AG化療方案(白蛋白紫杉醇200mg +吉西他濱L 4g ivgtt dl),此次入院后完善相關檢查,患者病理診斷明確,ECOG評分合格,心 電圖及生化檢查合格,排除相關禁忌,經主任同意,2023-03-09行腹腔干+腸系膜上動脈化療術(白蛋白紫杉醇100mg+吉西他濱0.4g IA),并子樞星止嘔,愛麗安護胃,美能護肝。
      on Feb. 9, 2023 and Mar. 2, 2023, Our department performed C5 treatment of AG program: AG chemotherapy program (nab-paclitaxel 200mg + gemcitabine L 4g ivgtt dl), relevant examinations were completed after admission, the patient’s pathological diagnosis was clear, and the ECOG score was qualified, the electrocardiogram and biochemical examination were qualified, and the relevant contraindications were excluded. With the consent of the director, celiac trunk + superior mesenteric artery chemotherapy (nab-paclitaxel 100mg + gemcitabine 0.4g IA) was performed on March 09, 2023, with Granisetron Hydrochloride Tablets for relieving vomiting, Ilaprazole Enteric-coated Tablets  for protecting the stomach, and SNMC for protecting liver.
      余治療于門冬胰島素30早12u-晚 11u皮下。
      Insulin aspart 30 was given with 12u in the morning and 11u in the afternoon as treatment by subcutaneous injection
      查患者舌淡紅,苔薄白,脈細,證屬“胰癌脾氣虛證”,子通關藤、康艾清熱解毒抗腫痛,正得康膠囊扶正抗腫瘤,配合耳針益氣扶正。
      The patient had a pale red tongue, thin white fur, and thready pulse. The syndrome belongs to “pancreatic cancer with spleen deficiency syndrome”.  Medicines of Marsdeniae Tenacissimae Caulis,Kang‘ai Zhusheye,Zhengdekang capsule  and acupunctur threapy are given for cancer treatment.
      經治療,患者癥情緩解,經上級醫師同意,準予出院。
      After that, the patient’s symptoms were relieved, and the patient was allowed to leave the hospital with the consent of the superior physician.
      合并癥
      Complications
      None
      出院時情況(癥狀與體征) 出院時患者左側腹部脹痛較前緩解,無明顯不適,乏力較前緩解,胃納可,二便調,夜寐一般“查體:神清,精神可,全身皮膚粘膜未見黃染,無水腫及皮下出血點及結節,淺表淋巴結未及腫大,鞏膜正常,口唇無紫紺。
      Health status at discharge (symptoms and signs) When discharged from the hospital, the left abdomen pain of the patient was relieved without obvious discomfort, fatigue was relieved, appetite was acceptable, night soil and urine were normal, and night sleep was normal. No jaundice was found on the skin or mucous membranes of the whole body, no edema, no subcutaneous bleeding points or nodules, superficial lymph nodes were not enlarged, the sclera was normal, and the lips were not cyanotic.
      雙肺呼吸音清,未聞及干濕啰音。
      Breath sounds in both lungs were clear. Dry or wet rales were not heard.
      心率76次/分,律齊,各瓣膜區未聞及病理性雜音腹平軟。
      The heart rate was 76 beats/min and regular, No pathological murmurs were heard in each valve area, and the abdomen was flat and soft.
      腹壁睜脈無曲張,無壓痛及反跳痛,肝脾肋下未觸及,未及包塊,肝區叩痛(-)。
      No varicose veins in the abdominal wall, no tenderness or rebound pain, no palpation of the liver and spleen under the ribs, no mass, There is pain on percussion in the liver area (-).
      無移動性濁音,無腎區叩擊痛,腸鳴音4次/分,無雙下肢水腫,四肢肌力肌張力正常,生理反射正常,病理反射未引出。
      No shifting dullness, no percussion pain in the kidney area, bowel sounds 4 times/min, no lower limb edema, normal muscle strength and muscle tone in the four limbs, normal physiological reflexes, and no pathological reflexes.
      出院后用藥及建議
      Medication and advice after discharge
      .出院帶藥:得康膠囊*1盒 每日三次,每次4粒 口服
      Discharge medicine: Dekang Capsule*1 box, three times a day, 4 capsules each time orally
      .自備藥:門冬胰島索30 早12u-晚11u皮下。
      Self-prepared medicine: insulin aspart 30 12u-in  the morning 11u at night by subcutaneous injection.
      .藥物潛在副作用:詳見說明書
      . Potential side effects of the medicine: see the instructions for details
      .后續醫療服務的安排:門診隨訪,定期及查,如有不適及時就診.
      .Arrangement of follow-up medical services: outpatient follow-up, regular check-ups, and timely visit hospital if there is any discomfort.
      本院門診隨訪
      Outpatient follow-up in our hospital
      m掃描全能王創建
      /
      /
      上海中醫藥大學附屬龍華醫院出院小結
      Discharge Summary of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
      姓名:***   科別:腫瘤七科病區:二十六病區床號:14 住院號:0823817
      Name:  *** Department: Tumor the 7th Department Ward No.: 26  Bed No.: 14 Hospital No.: 0823817
      姓名:***  性別:女年齡:50歲住院號:0823817
      Name: *** Gender: Female  Age: 50 Admission No.: 0823817
      入院日期 2023-03-07 09:01出院日期 2023-03-10 15:00門診診斷
      Admission Date Mar. 7, 2023 09:01 Discharge Date Mar. 10, 2023 15:00 Outpatient Diagnosis
      中醫診斷:胰癌、脾氣虛證
      Traditional Chinese Medical Diagnosis: Pancreatic Cancer, Spleen Deficiency Syndrome
      西醫診斷:胰腺惡性腫痛C-T4N1M1 (左側腎上腺、胃后壁、骨)2型循尿病
      Western medicine diagnosis: pancreatic malignant swelling and pain C-T4N1M1 (left adrenal gland, back wall of stomach, bone) type II diabetes
      入院診斷
      Admission diagnosis
      中醫診斷:胰癌、脾氣虛證
      Traditional Chinese Medical Diagnosis: Pancreatic Cancer, Spleen Deficiency Syndrome
      西醫診斷:腹腺惡性腫瘤C-T4N1M1 (左側腎上腺、胃后壁、骨)2型糖尿病
      Western medicine diagnosis: abdominal gland malignant tumor C-T4N1M1 (left adrenal gland, back wall of stomach, bone)  type II diabetes
      出院診斷
      Discharge diagnosis
      中醫診斷:胰癌、脾氣虛證
      Traditional Chinese Medical Diagnosis: Pancreatic Cancer, Spleen Deficiency Syndrome
      西醫診斷:胰腺惡性腫瘤C-T4N1M1 (左側腎上腺、胃后壁、骨)2型糖尿病
      Western medicine diagnosis: pancreatic malignant tumor C-T4N1M1 (left adrenal gland, back wall of stomach, bone) type 2 diabetes mellitus
      入院時主要癥狀及體征
      Main symptoms and signs on admission
      入院時患者左側腹部脹痛,按之痛甚,進食后緩解,乏力,胃納可,二便調,夜寐一股。
      When admitted to the hospital, the patient had distending pain in the left abdomen, which was very painful when pressed, and was relieved after having food. fatigue, normal appetite,  bowels and urine open, and normal night sleep.
      PE:神清,精神可,全身皮膚粘膜未見黃染,無水腫及皮下出血點及結節,淺表淋巴結未及腫大,鞏膜正常,口唇無紫紺。
      PE: good consciousness, energetic, no jaundice in skin mucosa of the whole body, no edema, subcutaneous bleeding points or nodules, no superficial lymph node enlargement, normal sclera, and no cyanosis of lips.
      雙肺呼吸音清,未聞及干濕啰音。
      Breath sounds in both lungs were clear. Dry or wet rales were not heard.
      心率80次/分,律齊,各瓣膜區未聞及病理性雜音腹平軟。
      The heart rate was 80 beats/min and regular, no pathological murmurs were heard in each valve area, and the abdomen was flat and soft.
      腹壁靜脈無曲張,無 壓痛及反跳痛,肝脾肋下未觸及,未及包塊,肝區叩痛(-).無移動性濁音,無腎區叩擊痛,腸鳴音4次/分,無雙下肢水腫,四肢肌力肌張力正常,生理反射正常,病理反射未引出。
      No varicose veins in the abdominal wall, no tenderness or rebound pain, no palpation of the liver and spleen under the ribs, no mass,  percussion pain in the liver area (-). No shifting dullness, no percussion pain in the kidney area, bowel sounds 4 times/min. No lower limbs edema, normal muscle strength and muscle tone of four limbs, normal physiological reflex, no pathological reflex elicited.
      主要檢查結果
      Main inspection results
      2023-03-08血常規:白細胞計數3.
      2023-03-08 Blood routine: white blood cell count
      40 x109/L ,中性粒細胞百分比66.
      3.40 x10^9/L , neutrophil percentage 66.
      1 % ,紅細胞計數4.14 xlO12/L ,血紅蛋白量111 g/L ,血小板計數224 x109/L ,超敏C反應蛋白<0. 50 mg/L ,血清淀粉樣蛋白A 35. 04 mg/L。
      1%, red blood cell count 4.14 x10^12/L, hemoglobin 111 g/L, platelet count 224 x10^9/L, hypersensitive C-reactive protein <0. 50 mg/L, serum amyloid A 35. 04 mg/L.
      生化:白蛋白(干式)38.9 g/L,丙氨酸氨基轉移酣(干式)17 U/L ,天冬氨酸氨基轉移酶(干式)21 U/L . γ-谷氨酰轉肽酶(干式)19 U/L ,肌酐(干式)38.3 umol/L ,尿素(干式) 4. 38 mmol/L , 尿酸(干式)218 umol/L .鉀(干式)5. 0 mmol/L,鈉(干式)137. 1 mmol/L。
      Biochemical: Albumin (dry) 38.9 G/L, Alanine Transaminotransferase (dry) 17 U/L, Aspartate Aminotransferase (dry) 21 U/L. Γ-glutamyl Transfer Peptidase (dry) 19 U/L, Creatinine (dry) 38.3 Umol/L, Urea (dry) 4.38 Mmol/L, Uric Acid (dry) 218 Umol/L, Potassium (dry) 5. 0 Mmol/L, Sodium (dry ) 137.1 Mmol/L.
      凝血: 凝血酶原時間11.8秒,國際標準化比值(INR) 1.04,活化部分凝血活酶時間25.8秒,D二聚體1.24,凝血因子VIII174 % t .
      Coagulation: Prothrombin Time 11.8 Seconds, International Normalized Ratio (INR) 1.04, Activated Partial Thromboplastin Time 25.8 Seconds, D Dimer 1.24, Coagulation Factor VIII 174 %
      2023-03-10門急診檢驗報告:白細胞計數5.
      2023-03-10 Outpatient emergency test report: white blood cell count 5.
      28 xI09/L,中性粒細胞絕對值 3.77 xlO9/L .紅細胞計數4.
      28 xI0^9/L, Absolute Value Of Neutrophils 3.77 XlO^9/L. Red Blood Cell Count 4.
      10 x10l2/L ,血紅蛋白量110 g/L I ,血小板計數195 x109/L . 超敏C反應蛋白<0. 50 mg/L 。
      10 x10^l2/L, Hemoglobin 110 g/L I, Platelet Count 195 X10^9/L. Hypersensitive C-reactive Protein <0. 50 mg/L.
      門急診檢驗報告:白蛋白(干式)38.3 g/L,丙氨酸氨基轉移酶(干式)15 U/L ,天冬氨酸氨基轉移酶(干式)18 U/L , Y-谷氨酰轉肽酶(干式)18 U/L ,肌酐(干式)43.6
      Outpatient and emergency test report: Albumin (dry ) 38.3 G/L, Alanine Aminotransferase (dry) 15 U/L, Aspartate Aminotransferase (dry) 18 U/L, Y-glucose Amyltranspeptidase (dry) 18 U/L, Creatinine (dry ) 43.6
      第1頁
      page 1
      m掃描全能王創建
      復旦大學附屬腫瘤醫院 核醫學科
      Cancer Hospital Affiliated to Fudan University  Department of Nuclear Medicine
      PET
      PET
      檢查報告單
      Physical Examination Report
      影像號:11407881
      Image number: 11407881
      姓名:*** 性別1女
      Name:   *** Gender: Female
      檢查方式核素
      Examination method: nuclide
      申請科室
      Department Application
      臨床論斷:
      Clinical conclusion:
      PET/CT 斷層
      PET/CT tomography
      藥物: FDG胰腺外科
      Medicine: FDG Pancreatic Surgery
      胰腺癌化療后
      Pancreatic Cancer After Chemotherapy
      年齡50 歲
      Age: 50
      檢查部位:全身
      Inspection Area: whole body
      劑量 6.048mCi
      Dosage 6.048mCi
      檢查日期,2023-01-31
      Inspection date, Jan. 31, 2023
      門診號 310104197210274823
      Clinic No. 310104197210274823
      床號
      Bed No.
      血糖:6. 2mmol/L
      Blood sugar: 6. 2mmol/L
      檢查項目:腫瘤全身斷層顯像
      Inspection items: Tumor whole body tomography
      給藥方式:靜脈注射 注射部位:右手腕
      Administration method: intravenous injection Injection part: right wrist
      檢查排號:25
      Queue number for examination: 25
      體檢發現多項腫瘤指標升高就診:2022. 9 本院PET/CT:肢體部軟組織腫塊影,FDG代謝增高,考再為MT可能大.侵犯左側腎上腺及胃后壁.2022.9本院EUS:質腺體部占位,活檢病理:腺癌.后化療4程。
      A number of tumor indicators were found to be elevated in the physical examination and visit the hospital: In Sept., 2022. PET/CT in our hospital: soft tissue mass shadow in the limbs, FDG metabolism increased, high MT possibility was considered. Invasion of the left adrenal gland and the back wall of the stomach. Sept. 2022 EUS in our hospital: Gland space occupying, biopsy pathology: adenocarcinoma. Chemotherapy with 4 courses.
      2023. 1
      Jan. 2023
      本院
      This hospital
      CA19-9:6351.
      CA19-9:6351.
      OOU/mI, CA19-9_H:6351. 00U/mI, CA125:52. 80U/ml,CA50:>500. 00lU/mL, CA242:>200. 00U/m
      OOU/mI, CA19-9_H:6351. 00U/mI, CA125:52. 80U/ml, CA50:>500. 00lU/mL, CA242:>200. 00U/m
      檢杳所見:
      Examination Result:
      禁食狀態下.靜脈注射F-18-FDG,體息約60分鐘,行PET/CT顯像,圖像顯示清晰,與前片對比(2022. 09.15).
      In the fasting state. F-18-FDG was injected intravenously, and rested for about 60 minutes. PET/CT imaging was performed, and the image was clearly displayed, comparing with the previous film (Sept. 15, 2022).
      胰腺癌化療后.肢體部軟組織腫塊影大小基本同前,邊界欠清,侵犯左側腎上腺及胃后壁,放射性攝取增高基本同前,SUVmax=4.1 (前片4.4):
      After chemotherapy for pancreatic cancer, the size of the soft tissue mass in the extremities is basically the same as before, with unclear borders, invading the left adrenal gland and the back wall of the stomach, and the increase in radioactive uptake is basically the same as before, SUVmax=4.1 (4.4 in the previous film):
      肝臟形態、大小正常,密度均勻, 放射性分布未見明顯異常.肝內外膽管皆未見明顯獷張;
      The shape and size of the liver were normal, the density was uniform, and there was no obvious abnormality in the distribution of radioactivity. There was no obvious swelling of the bile ducts inside and outside the liver;
      膽囊壁未見明顯增厚,未見放射性攝取異常增高灶:
      There was no obvious thickening of the gallbladder wall, and no abnormally increased radioactive uptake foci:
      脾臟大小正常,放射性分布均勻;
      The size of the spleen is normal and the distribution of radioactivity is uniform;
      腸道各段見少量生理性放射性攝?。?/td>
      A small amount of physiological radioactive uptake is seen in various segments of the intestinal tract:
      右側腎上腺形態未見明顯異常,未見明顯放射性異常攝??;
      There was no obvious abnormality in the shape of the right adrenal gland, and no obvious abnormal uptake of radioactivity;
      雙腎實質未見異常密度影及放射性異常增高灶,腎孟、腎盞未見明顯擴張;
      There were no abnormal density shadows and abnormally increased radioactive foci in the renal parenchyma, and no obvious expansion of the renal calices and pelvis;
      膀胱充盈欠佳;
      Poorly filling bladder;
      子客體積增大,左后緣凸起略低密度灶同前,子宮另見數個結節樣略高密度影,均未見放射性攝取增高;
      The volume of the uterus increases, the left posterior margin bulges slightly low density foci are the same as before, and several nodular with slightly high density shadows are seen in the uterus, all of which have no increased radiation uptake;
      雙側附件區未見明顯放射性異常攝?。?/td>
      No obvious abnormal radioactive uptake in the bilateral appendages:
      腹膜后、兩側髂血管旁及腹股溝未見明顯腫大淋巴結。
      No obvious enlarged lymph nodes were found in retroperitoneum, beside bilateral iliac vessels or groin.
      兩肺及理增粗,散在微小結節,均未見放射性攝取增高:縱隔及兩側肺門淋巴結未見明顯腫大及放射性異常攝?。菏彻芄鼙谖匆娒黠@增厚及放射性異常增高灶。
      The two lungs were thickened, with scattered tiny nodules, and no increased radioactive uptake was found: no obvious enlargement and abnormal radioactive uptake were found in the mediastinal and bilateral hilar lymph nodes; no obvious thickening of the esophageal wall and abnormally increased radioactive foci were found.
      雙側乳腺未見異常放射性分布:雙側腋窩及內乳未見明顯腫大淋巴結及放射性攝取異常增高灶。
      No abnormal radiation distribution was found in bilateral breasts: no obvious enlarged lymph nodes or abnormally increased radioactive uptake foci were found in bilateral axillaries and inner breasts.
      鼻咽頂后壁及兩側壁未見明顯增厚,咽隱窩及咽旁間隙清晰:
      The posterior wall of the nasopharyngeal roof and both sides were not thickened, and the pharyngeal recesses and parapharyngeal space were clear:
      雙側上頜竇、篩竇及堞竇 結構未見明顯異常,黏膜未見明顯增厚:
      There was no obvious abnormality in the structure of the bilateral maxillary sinus, ethmoid sinus, and castellation sinus, and no obvious thickening of the mucosa:
      口咽部、兩側梨狀窩、甲狀腺未見明顯異常密度影及放射性異常增高灶,新見雙側鎖骨上小淋巴結,放射性攝取輕度增高,SUVmax=2.7;
      no obvious abnormal density shadow and abnormally increased radioactive focus at Oropharynx, bilateral pyriform sinuses or thyroid, new bilateral supraclavicular small lymph nodes appears with slightly increased radioactive uptake, SUVmax=2.7;
      雙側 上頸部小淋巴結,放射性攝取輕度增高,SUVmax=2. 6。
      The radioactive uptake was slightly increased in the small lymph nodes of the upper neck bilaterally, SUVmax=2.6.
      大腦各葉、雙側基底節、丘腦及兩側小腦放射性分布對稱,未見明顯放射性攝取異常增高或減低區;CT平掃顯示腦實質內未見異常密度影,中線結狗居中:腦溝、腦裂、腦池未見明顯增寬、擴張。
      The radioactivity distribution in each lobe of the brain, bilateral basal ganglia, thalamus and bilateral cerebellum is symmetrical, and there is no obvious abnormal increase or decrease of radioactivity uptake; CT plain scan showed that there was no abnormal density shadow in the brain parenchyma, and the midline structure was in the middle: the sulcus, fissure and cistern were not significantly widened or expanded.
      新見胸骨體混合性密度改變,右側股骨上段成骨性改變,均放射性攝取異常增高, SUVmax=6. 3:所見余處骨骼放射性分布未見明顯異常。
      The mixed density change of the sternum body and the osteogenic change of the right upper femur are newly seen, and the radioactive uptake is abnormally high, SUVmax=6 3: There is no obvious abnormality in the radioactive distribution of the remaining bones.
      SUVmax;最大標準攝取值 檢查結論「
      SUVmax; maximum standard intake value inspection conclusion
      與前對比:
      Compared with before:
      1.肢腺癌化療后,肢體MT較前相仿,仍FDG代謝異常增高,侵犯左側腎上腺及胃后壁:新見胸骨、右側股骨上段轉移;新見兩側鎖骨上淋巴結轉穢可能:兩肺散在小結節,密切隨訪。
      1. After chemotherapy for pancreatic cancer, the limb MT was similar as before, but the FDG metabolism was still abnormally high, and the left adrenal gland and the posterior wall of the stomach were invaded: the sternum and the upper part of the right femur were newly found to metastasize; The newly seen bilateral supraclavicular lymph node metastasis is possible: scattered small nodules in both lungs, close follow-up is needed.
      2:雙側上頸部淋巴結炎性增生;子宮多發肌瘤可能。
      2: Inflammatory hyperplasia of bilateral upper cervical lymph nodes; multiple fibroids of the uterus  is possible.
      報告醫生:李楠審核醫生:劉曉晟
      Reporting doctor:Nan  Li  Reviewing doctor: Xiaosheng Liu
      報告日期:2023-01-31 14:14:56審核日期:2023-01-31 16:31:21
      Reporting Date: Jan. 31, 2023 14:14:56 Reviewing Date: Jan. 31, 2023 16:31:21
      上海市徐匯區東安路270號電話:(021) 64175590-86908復旦大學附屬腫病醫院
      No. 270, Dong’an Road, Xuhui District, Shanghai Tel: (021) 64175590-86908 Cancer Hospital Affiliated to Fudan University
      (本檢查報告及圖像僅供參考重要資料請妥善保存)tMwfKd C-
      (This inspection report and images are for reference only, please keep the information properly)
      m掃描全能王創建
      復旦大學附屬腫痛醫院  核醫學科
      Department of Nuclear Medicine, Cancer Hospital, Affiliated to Fudan University
      PET 檢查報告單
      PET inspection report
      影像號 11407881
      Image number 11407881
      檢查日期 2022/09/15
      Inspection date: Sept. 15, 2022
      姓名:***  性別:女
      Name: ***Gender: Female
      檢查方式: PET/CT斷層
      Inspection method: PET/CT tomography
      核素: 18F藥物:FDG
      Nuclide: 18F Medicine: FDG
      申請科室:胰腺外科
      Department Application: Pancreatic Surgery
      臨床診斷:胰腺癌
      Clinical Diagnosis: Pancreatic Cancer
      年齡:49 8門診號:310104197210274823
      Age: 49  Clinic No.: 310104197210274823
      檢查部位:全身       床號:給藥方式:靜脈注射
      Examination Area: Whole Body Bed No.: Administration Method: Intravenous Injection
      劑量: 5. 285mOI          血糖:10.0mmol/L     注射部位:右手背
      Dosage: 5. 285mOI Blood sugar: 10.0mmol/L Injection site: Back of right hand
      檢查項目:腫瘤全身斷層顯像檢查排號,46
      Inspection items: Tumor whole body tomography inspection Queue Number: 46
      簡要病史:體檢發見多項腫瘤指標升高:2022.09. 14本院CT:胰腺體尾部MT,侵及脾動靜脈與左腎上腺,請結合臨床及其他其他檢查。
      Brief medical history:  Multiple tumor indicators increasing was found in physical examination: Sept. 14, 2022 CT in our hospital: MT of the pancreas body tail, invading the splenic arteriovenous and left adrenal gland, please combine with clinical and other examinations.
      胰周、脾門區數枚強化淋巴結,部分稍大,轉修待排.
      There were several enhanced lymph nodes in the peripancreatic and splenic hilum area, some of which were slightly larger.
      檢查所見:
      Examination Results:
      禁食狀態下,靜脈注射F-18-FDQ,休息約60分鐘,行PET/CT顯像,圖像顯示清晰.
      In the fasting state, F-18-FDQ was injected intravenously, rested for about 60 minutes, and PET/CT imaging was performed, and the images were clearly displayed.
      胰體部軟組織腫塊影,約4.2*2.9cm.侵犯左側腎上腺及胃后壁,放射性攝取異常增 高,SUVmax=4.4:
      The soft tissue mass shadow in the body of the pancreas is about 4.2 * 2.9 cm. It invades the left adrenal gland and the posterior wall of the stomach, and the radioactive uptake is abnormally high. SUVmax=4.4:
      肝臟形態、大小正常,密度均勻,放射性分布未見明顯異常,肝內外膽管未見明顯擴張:
      The shape and size of the liver were normal, the density was uniform, the distribution of radioactivity was normal, and the intrahepatic and extrahepatic bile ducts were not obviously dilated:
      膽囊壁未見明顯增厚,未見放射性攝取異常增高灶:脾臟大小正常,放 射性分布均勻:
      There is no obvious thickening of the gallbladder wall, no abnormally increased radioactive uptake foci: the spleen is normal in size, and the radioactivity is evenly distributed:
      腸道各段見少量生理性放射性攝??;右例腎上腹形態未見明顯異常,未見明顯放射性異常攝??;
      A small amount of physiological radioactive uptake was seen in each segment of the intestinal tract; no obvious abnormality was seen in the right renicapsule, and no obvious abnormal radioactive uptake was seen;
      雙腎實質未見異常密度影及放射性異常增高灶,腎盂、腎盞未見明顯擴張:膀胱充盈良好,膀胱壁未見異常密度影;子宮體積增大,左后緣凸起略低密度灶, 約5.
      There were no abnormal density shadows or abnormally increased radioactive foci in the kidney parenchyma, and no obvious expansion of the renal pelvis and calyces; the bladder was well filled, and no abnormal density shadows were seen in the bladder wall; about
      8*4. 1cm,放射性分布缺損;雙側附件區未見明顯放射性異常攝?。焊垢购?、兩側髂血管旁及腹股溝未見明顯腫大淋巴結。
      5.8*4. 1cm, radioactive distribution defects; no obvious abnormal uptake of radioactivity in the bilateral appendages; no obvious enlarged lymph nodes in the retroperitoneal abdomen, both sides of the iliac vessels or groin.
      兩肺紋理清晰,未見實質性病變及放射性攝取異常增高灶,縱隔及兩側肺門淋巴結未見明顯腫大及放射性異常攝?。?/td>
      The texture of both lungs was clear, no substantial lesion and abnormally increased radioactive uptake were found, no obvious enlargement and abnormal radioactive uptake of mediastinal and bilateral hilar lymph nodes were seen;
      食管管壁未見明顯增厚及放射性異常增高灶.雙側孔腺未見異常放射性分布;
      There was no obvious thickening of the esophageal wall and abnormally increased radioactivity. There was no abnormal radioactive distribution in the bilateral orifice glands;
      雙側腋窩及內乳未見明顯腫大淋巴結及放射性攝取異常增高灶。
      There were no obvious enlarged lymph nodes and abnormally increased radioactive uptake foci in the bilateral armpits and inner breasts.
      鼻咽頂后壁及兩側壁未見明顯增厚,咽隱窩及咽旁間隙清晰;
      There is no obvious thickening of the top and back wall and both sides of the nasopharynx, and the pharyngeal recess and parapharyngeal space are clear;
      雙側上頜竇、篩竇及蝶竇結構未見明顯異常,幼膜未見明顯增厚;
      Bilateral maxillary sinus, ethmoid sinus and sphenoid sinus structures are normal, and mucosa is not significantly thickened;
      口咽部、兩側梨狀窩、甲狀腺未見明顯異常密度影及放射性異常增高灶,雙側頸部及鎖骨上淋巴結未見明顯腫大及放射性異常攝取。
      Oropharynx, bilateral pyriform sinuses, and thyroid had no obvious abnormal density shadow or abnormally increased radioactive focus, and bilateral neck and supraclavicular lymph nodes had no obvious swelling and abnormal radioactive uptake.
      大腦各葉、雙側基底節、丘腦及兩側小腦放射性分布對稱,未見明顯放射性攝取異常增高或減低區:
      The distribution of radioactivity in the lobes of the brain, bilateral basal ganglia, thalamus, and bilateral cerebellum is symmetrical, and there is no obvious abnormally increased or decreased radioactive uptake area:
      CT平掃顯示腦實質內未見異常密度影,中線結構居中:
      Plain CT scan showed no abnormal density shadow in the brain parenchyma, and the midline structure was centered:
      腦溝、腦裂、腦池未見明顯增寬、擴張。
      Cerebral sulci, fissures, and brain cisterns were not significantly widened or expanded.
      所見骨骼放射性分布未見明顯異常。
      There was no obvious abnormality in the distribution of radioactivity in the bones.
      ■I
      ■I
      SUVmax:最大標準攝取值
      SUVmax: maximum standard uptake value
      檢查結論:
      Inspection Results:
      胰體部軟組織腫塊影,FDG代謝增高,考慮為MT可能大,侵犯左側腎上腺及胃后壁.
      The soft tissue mass in the body of the pancreas and increased FDG metabolism is considered that the MT possibility is high, invading the left adrenal gland and the posterior gastric wall.
      子宮肌瘤伴囊變.
      Uterine fibroids with cystic changes.
      報告醫生:徐俊彥
      Reporting doctor:  Xu Junyan
      報告日期:2022/09/15 21:08:27
      Date of report: Sept. 15, 2022  21:08:27
      trim
      審核醫生:胡四龍
      Reviewing Doctor:   Hu Silong
      審核日期:2022/09/16 07:50:18
      Review Date: 2022/09/16 07:50:18
      上海市徐匯區東安路270號 電話:(021) 64175590-86908(本檢查報告及圖像僅供參考乖要資料請妥善保存)
      No. 270 Dong’an Road, Xuhui District, Shanghai Tel: (021) 64175590-86908 (This inspection report and images are for reference only, please keep the important information properly)
      復旦大學附屬腫皰醫院
      Cancer Hospital Affiliated to Fudan University
      FwDm Ufilv?r?Jty ShaA?M*l Cmc-
      復旦大學附屬腫瘤醫院放射診斷報告(CT)
      Radiological diagnosis report (CT) of Cancer Hospital Affiliated to Fudan University
      姓名: ***性別:女。
      Name:  *** Gender: Female.
      年齡:49歲 病區:放射學檢查號碼:11407881
      Age: 49 Ward: Radiology Examination No.: 11407881
      門診號:310104197210274823      住院號:    科室:胰腺外科病床
      Clinic No.: 310104197210274823 Hospitalization No.: Department: Pancreatic surgery  Ded:
      臨床診斷:胰尾惡性腫瘤送檢醫生的要求:胰腺CT(增強)
      Clinical diagnosis: Malignant tumor of the pancreas  tail Doctor’s request for examination: CT of the pancreas (enhanced)
      檢查部位和名稱:胰腺CT (增強)檢查時間:2022 -9 -1319:24:20
      Examination site and name: Pancreas CT (enhanced) Examination time: Sept. 13, 2022 19:24:20
      檢查方法,厚層5mm間隔5mm【碘】造影劑100ml速率l.5ml/s延時 動脈期22s靜脈期75s
      Inspection method, thick layer 5mm, interval 5mm [iodine] contrast agent 100ml rate 1.5ml/s delay arterial phase 22s venous phase 75s
      放射學表現胰腺體尾部腫塊.約60*42mm,形態不規則,輕中度不均勻強化.病變包繞脾動靜
      Radiological manifestations: a mass in the tail of the pancreas. About 60*42mm, irregular in shape, with mild to moderate uneven enhancement. The lesion surrounds the spleen
      脈與部分左腎上腺.遠端抵近脾門,局部與胃壁貼鄰.胰周、脾門區數枚也強化淋巴結,部分稍大。
      artery-vein and part of the left adrenal gland. The distal end is close to the splenic hilum, and some part is adjacent to the stomach wall. Several lymph nodes in the peripancreatic and splenic hilus areas also strengthen, and some are slightly larger.
      肝臟大小、形態正常,肝內目前未見明確占位性病變,肝內血管走行正常,肝內外膽管無擴張。
      The size and shape of the liver were normal, no clear space-occupying lesions were found in the liver, the blood vessels in the liver run normally, and the extrahepatic and extrahepatic bile ducts were not dilated.
      脾不大,右腎上腺大小形態及密度正常,雙側腎臟對稱。
      The spleen was not enlarged, the size, shape and density of the right adrenal gland were normal, and the bilateral kidneys were symmetrical.
      大小及形態正常,未見局灶性密度異常.腹膜后未見腫大淋巴結,腹腔內未見積液.
      The size and shape were normal, and no focal density abnormalities were found. There was no enlarged lymph node in the retroperitoneum, and no effusion in the abdominal cavity.
      放射學診斷:
      Radiological diagnosis:
      胰腺體尾部MT,侵及脾動脈與左腎上腺,請結合臨床及其他檢查。
      MT at the tail of the pancreas, invading the splenic artery and left adrenal gland, please combine with clinical and other examinations.
      胰周、脾門區數枚強化淋巴結,部分稍大,轉移待排,密切隨訪.
      There were several enhanced lymph nodes in the peripancreatic and splenic hilum area, some of which were slightly larger, and the metastasis was waiting to be excluded. Close follow-up was needed.
      報告醫師:彭琴
      Reporting physician:  Qin Peng
      報告時間:2022-09T4 12:11:13
      Reporting time: Sept. 14, 2022 12:11:13
      審核醫師
      Auditing Physician:
      審核時間;2022-09-11
      Reviewing Date; 2022-09-11
      15:40:38
      15:40:38
      1.本報告的僅供性床醫師參考.2.本報告為乖要資料,請妥為保管?
      1. This report is only for the reference of clinicians. 2. This report is important information, please keep it safe
      復旦大學附屬腫瘤醫院放射診斷報告(CT)
      Radiological Diagnosis Report (CT) Of Cancer Hospital Affiliated To Fudan University
      姓名:馀東雁性別 女 年齡:50  病區:,放射學檢查號碼:11407881
      Name: ***  Gender: Female Age: 50 Ward: Radiology Examination No.: 11407881
      門診號:310104197210274823住院號:2119695科室:胰腺膽道專病門診病床,
      Outpatient No.: 310104197210274823 Inpatient No.: 2119695 Department: Outpatient For Pancreas And Biliary Tract Diseases,  Bed No.:
      臨床診斷:胰尾惡性腫瘤送檢醫生的要求:胰腺CT (增強)
      Clinical diagnosis: Malignant tumor of the tail of the pancreas. The doctor’s request for examination: CT of the pancreas (enhanced)
      檢查部位和名稱: 胰腺CT (增強)檢查時間:M2022-11-1510:51:49
      Examination site and name: Pancreas CT (enhanced) Examination time:Nov. 15, 2022 10:51:49
      檢查方法:層厚5mm間隔5mm【碘】造影劑100ml速率1.5ml/s延時 動脈期22s 靜脈期75s
      Inspection method: layer thickness 5mm interval 5mm [iodine] contrast agent 100ml rate 1.5ml/s delay arterial phase 22s venous phase 75s
      放射學表現:對比2022-9-13前片:胰腺MT治療后,胰腺體尾部腫塊較前增大,約58*61mm,
      Radiological manifestations: Compared with the  film got on September 13, 2022: After pancreatic MT treatment, the mass at the tail of the pancreas increased, about 58*61mm,
      形態不規則,輕中度不均勻強化,病變包繞脾動靜脈與部分左腎上腺,遠端抵近脾門,局部侵犯胃壁。
      Irregular in shape, mild to moderate uneven enhancement, the lesion surrounds the splenic artery and vein and partial left adrenal gland, the distal end is close to the splenic hilum, and partially invades the gastric wall.
      脾周、脾門區數枚強化淋巴結較前相仿,部分稍大.肝臟大小、形態正常.肝內目前未見明確占位性病變,肝內血管走行正常,肝內外膽管無擴張.
      Several enhanced lymph nodes around the spleen and in the splenic hilum area are similar as before, some of them are slightly larger. The size and shape of the liver are normal. There is no definite space-occupying lesion in the liver at present, the blood vessels in the liver are normal, and the intrahepatic and extrahepatic bile ducts are not dilated
      脾不大,右腎上腺大小形態及密度正常.雙側腎臟對稱,大小及形態正常,未見局灶性密度異常.腹膜后未見腫大淋巴結,腹腔內未見積液.
      The spleen was not enlarged, and the size, shape, and density of the right adrenal gland were normal. The bilateral kidneys were symmetrical, with normal size and shape, and no focal density abnormalities. No enlarged lymph nodes were found in the retroperitoneum, and no fluid was found in the abdominal cavity.
      放射學診斷:
      Radiological diagnosis:
      腴腺MT較前增大,侵及脾動靜脈與左腎上腺及胃壁.
      Pancreatic MT was larger than before and invaded splenic artery and vein, left adrenal gland and gastric wall
      脾周、脾門區數枚強化淋巴結較前相仿,部分稍大,繼續隨訪.
      Several enhanced lymph nodes in the perisplenic and splenic hilum area were similar as before, some were slightly larger, and the follow-up was needed.
      報告醫師?彭琴審核醫師:
      Reporting Physician: Qin Peng Reviewing Physician:
      報告時間:2022-11-16 12:55:32 審核時同:2022-11-17 09:55:16
      Reporting time: Nov.. 16, 2022 12:55:32 Reviewing time: Nov. 17, 2022 09:55:16
      I.本報告單僅供臨床醫師參考.2.本報告為重要要資料,請妥為保管.
      I. This report is only for reference of clinicians. 2. This report is important information, please keep it safe.
      m掃描全能王創建
      復旦大學附屬腫瘤醫院放射診斷報告(CT)
      Radiological Diagnosis Report (CT) Of Cancer Hospital Affiliated To Fudan University
      姓名:***性別:女 年齡: 50  病區:放射學檢查號碼,11407881
      Name:  *** Gender: Female Age: 50 Ward: Radiological Examination No., 11407881
      門診號:310101197210274823 住院號:2119695 科室:股腺膽道專病門診病床?
      Outpatient No.: 310101197210274823 Inpatient No.: 2119695 Department: Femoral gland and biliary tract disease outpatient   Bed:
      臨床診斷:胰尾惡性腫瘤送檢醫腳的娜,覷腺CT (增強)
      Clinical diagnosis: Malignant tumor of the tail of the pancreas The Request of Examination Physican,  pancreas CT (enhanced)
      檢查部位和名稱?胰腺CT (增強)檢查時間,2023-01-2808:20:26
      Examination site and name: Pancreas CT (enhanced) Examination Time, Jan. 28, 2023 08:20:26
      檢查方法:層厚5mm間隔5mm【碘】造影劑100ml速率l.5ml/s延時 動脈期22s靜脈期75s
      Inspection method: layer thickness 5mm interval 5mm [iodine] contrast agent 100ml rate 1.5ml/s delay arterial phase 22s venous phase 75s
      放射學表現,對比2022-11-15前片,腆腺MT治療后,膚腺體尾部腫塊大致同前,約48
      Radiological manifestations, compared with the previous film on November 15, 2022, After MT treatment of the pancreas, the mass in the tail of the pancreas is roughly the same as before,, about 48
      *65mm,形態不規則,輕中度不均勻強化,病變包繞脾動靜脈與部分左腎上腺,遠端抵近脾門,局部侵犯胃壁.胰周、脾門區數枚強化淋巴結較前相仿,部分梢大。
      *65mm, irregular shape, mild to moderate heterogeneous enhancement, the lesion surrounded the splenic artery and vein and some part of the left adrenal gland, the distal end approached the splenic hilum, and partially invaded the gastric wall. Several enhanced lymph nodes in the peripancreatic and splenic hilum area were similar as before, some of which are larger.
      肝臟大小、形態正常,肝內目前未見明確占位性病變,肝內血管走行正常,肝內外膽管無擴張.脾不大,右腎上腺大小形態及密度正常.雙側腎臟對稱,大小及形態正常,未見局灶性密度異常,腹膜后未見腫大淋巴結,腹腔內未見積液.
      The size and shape of the liver are normal, no clear space-occupying lesions are found in the liver, the blood vessels in the liver run normally, and the extrahepatic bile ducts are not dilated. The spleen is not enlarged, and the size, shape and density of the right adrenal gland are normal. , no focal density abnormalities, no enlarged lymph nodes in the retroperitoneum, no effusion in the abdominal cavity.
      放射學診斷;
      Radiological diagnosis;
      胰腺MT大致同前,侵及脾動靜脈與左腎上腺及胃壁。
      Pancreatic MT is roughly the same as before, invading the splenic artery and vein, left adrenal gland and gastric wall.
      胰周、脾門區數枚強化淋巴結較前相仿,繼續隨訪。
      Several enhanced lymph nodes in the peripancreatic and splenic hilum area are similar as before, and the follow-up was needed.
      報告醫師:周嘉音
      Reporting physician:  Jiayin Zhou
      報告時間i 2023-01-29 13:17:04
      Reporting time: Jan. 29, 2023 13:17:04
      審核醫師:
      Reviewing Physician:
      審核時間:2023-01-29 13:23:17
      Review time: Jan. 29, 2023 13:23:17
      本報告單僅供臨床醫肺參考.2.本報告為重要資料,請妥為保管.
      This report is only for clinical reference. 2. This report is important information, please keep it safe.
      掃描全能王創建

      迪朗上海翻譯公司正規涉外翻譯機構,由于普通翻譯公司的中文章沒有涉外效力,為滿足上海涉外翻譯蓋章認證需求,經上海市局評估后特批準上海迪朗備案和使用中英文“涉外翻譯專用章”。外交部、司法部、法院、各國使館、各國機構認可,蓋章證件或譯文官方認可、暢通全球。

      翻譯蓋章事項說明

      ★為何需要迪朗翻譯社為您辦理認證?

      1、從翻譯公證、認證,完全一貫作業,您可充分節省作業時間,掌握時效免除需多地奔波的勞頓之苦,更不必看公家機關經辦人員的臉色。

      2、多年經驗,專業翻譯翻譯,并簽名負責,翻譯后的文書譯文流暢優美。

      ★何謂公證?何謂認證?

      ◇公證,以法律用語來說,為公證人就請求人請求公證之法律行為或私權事實賦予公證力,證明該項法律行為之作成或該項事實之存在。

      ◇認證,則是公證人就請求人請求認證之文書,證明其文書之作成或形式上為真正。因此公證與認證雖有性質上之差異,但仍有其共通性之存在,故除公證法有特別規定外,認證準用公證之規定。

      ◇原則上,公證書由公證人製作而成,認證文書則由請求人提出,經公證人審閱內容,請求人當面簽名或承認為其簽名后,由公證人蓋認證章,完成認證程序。

      ★認證有什么好處?

      1、不論是國外取得之私人文件要在國內使用,或是國內之私人文件要拿到國外使用,例如結婚證書、出生證明、畢業證書等,經翻譯成當地文字后,均會面臨要負責證明其為真實的問題。一般私文書應由舉證人證明為真,不過民事訴訟法第三百五十八條第一項規定,私文書經公證人之認證者,推定為真正。因此可藉由認證的程序,免除舉證之責任,此謂之舉證責任之轉換。因此經過認證之私文書,其證據力便相當充分。

      2、涉及私權事實之公文書原來或正本,經表明係持往境外使用者,公證人得因當事人或其他關係人之請求予以認證。公證人作成之認證書,其真實性在國際間也是被廣泛承認的,因而涉及私權事實之公文書如戶籍謄本、印鑑證明書、死亡證明書、無犯罪紀錄證明書等,經公證人認證后,均可持往國外使用。

      ★需要多久的時間可以拿到經翻譯公證、認證后的文件?

      1、視文件的難易程度而定,翻譯部分約需1~3天,公證需要1天,因此通常最快也需要2天。

      2、迪朗翻譯社排除萬難,對于急件部分有特殊辦理程序,只要您在當天下午2點以前持必備之相關文件正本給我們,隔天下午6點以前您就可以拿到熱騰騰的翻譯公證/認證文件了。

      ★可辦理翻譯公證、認證的文件有哪些語言?哪些種類?

      語  種:英文、中文、日文、韓文、德文、法文、西班牙文、泰文、越南文等。

      文件類別:畢業證書、成績單、戶籍謄本、在職證明、離職證明、結婚證明書、出生/死亡證明、兵役證明(退伍令)、離婚協議書、護照、各類執照、銀行存款證明、土地/建物權狀、公司營利事業登記證、體檢表(健康證明)、股東名冊、財務報表、稅額申報書、扣繳憑單、納稅證明等各式文件翻譯。

      ★有什么需要注意的事項?

      1、若您的文件乃由國外攜回,且需要辦理公證時,必須先經過上海在當地的駐外辦事處之驗證,我們方可依法辦理該文件之認證。

      2、若您的文件要攜至國外使用,若為機關核發者,請務必辦理正本,以為公證人參考之佐證。辦理翻譯本公證后,我們的譯本會連綴于原文之上,供您于國外單位審核之用。

      注:所謂驗證,乃由領務人員就請求人請求證明或認證外國文書,以驗明、比對文書上之簽字、鈐印或以其他適當方式予以查證。

      迪朗翻譯服務承諾:屏幕快照 2018-04-16 下午7.38.57
      1、江、浙、滬免費快遞服務!
      2、譯文定稿前,會將翻譯初稿發客戶確認,如有疑異,可提供免費修改直到滿意為止!
      3、外地客戶亦可享受快捷、高質的證件翻譯蓋章服務,無需您的原件,只須將證照原件掃描或拍照給我們,第二天便可以得到譯文及蓋章翻譯件。
      4、江、浙、滬地區實現24小時交付,其它地區實現48小時交付。

      迪朗翻譯如何保證翻譯質量?

      迪朗上海翻譯公司是一家正規的上海認證翻譯機構,迪朗翻譯將質量看做是企業的生命,我們通過以下幾方面來保證我們自始至終為客戶提供著高質量的翻譯服務: 項目資源不僅包括譯員,還包括從事翻譯校對、頁面布局、質量控制、編輯和語料庫采編和建立的翻譯輔助人員,項目經理是整個翻譯團隊的負責人,負責項目小組的組建、協調和管控。我們的所有翻譯都擁有全國翻譯專業資格(水平)證書,同時都具備五年以上的翻譯經驗。全國翻譯專業資格(水平)考試(China Accreditation Test for Translators and Interpreters – CATTI)是受國家人力資源和社會保障部委托,由中國外文出版發行事業局(China Foreign Languages Publishing Administration)負責實施與管理的一項職業資格考試,已經納入國家職業資格證書制度,是一項在全國實行的、統一的、面向全社會的翻譯專業資格(水平)認證,是對參試人員口譯或筆譯方面雙語互譯能力和水平的評價與認定。翻譯專業資格(水平)考試開設多個語種,包括英、日、俄、德、法、西班牙、阿拉伯等語種,各語種分設四個級別??荚嚨燃墑澐峙c專業能力如下:

      1 資深翻譯:
      長期從事翻譯工作,具有廣博科學文化知識和國內領先水平的雙語互譯能力,能夠解決翻譯工作中的重大疑難問題,在理論和實踐上對翻譯事業的發展和人才培養作出重大貢獻。
      2 一級口譯、筆譯翻譯:
      具有較為豐富的科學文化知識和較高的雙語互譯能力,能勝任范圍較廣、難度較大的翻譯工作,能夠解決翻譯工作中的疑難問題,能夠擔任重要國際會議的口譯或譯文定稿工作。
      3 二級口譯、筆譯翻譯:
      具有一定的科學文化知識和良好的雙語互譯能力,能勝任一定范圍、一定難度的翻譯工作。
      4 三級口譯、筆譯翻譯:
      具有基本的科學文化知識和一般的雙語互譯能力,能完成一般的翻譯工作。
      人事部翻譯專業資格證書三級 人事部翻譯專業資格證書二級

       

       

      翻譯語種

      a片视频国产无码,天天精品天天操,国产精品福利在线观看播放,欧美三级99影视